Spire Wealth Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Spire Wealth Management’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$619	Hold	66	–	–	﹤0.01%	2198
2026 Q1	$620	Hold	66	–	–	﹤0.01%	2218
2025 Q4	$537	Hold	66	–	–	﹤0.01%	2287
2025 Q3	$835	Buy	+66	New	+$628	﹤0.01%	2300
2025 Q1	–	Sell	-66	Closed	-$779	–	2489
2024 Q4	$779	Buy	+66	New	+$1.11K	﹤0.01%	2402
2022 Q3	–	Sell	-67	Closed	-$1K	–	2247
2022 Q2	$1K	Buy	+67	New	+$648	﹤0.01%	2479
2022 Q1	–	Sell	-1,500	Closed	-$28K	–	2579
2021 Q4	$28K	Buy	+1,500	New	+$40.6K	﹤0.01%	1983
2021 Q2	–	Sell	-2,000	Closed	-$117K	–	2648
2021 Q1	$117K	Buy	+2,000	New	+$131K	﹤0.01%	1330

Other funds holding CRBP

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

Spire Wealth Management's CRBP Position: Q2 2026 in Review

Spire Wealth Management held its Corbus Pharmaceuticals (CRBP) position steady in Q2 2026 at 66 shares worth $619. The position accounts for ﹤0.01% of the portfolio, ranked #2198.

Spire Wealth Management first reported a position in CRBP in Q1 2021 and has held it in 8 quarters since. The position peaked at $117K in Q1 2021. 6 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

Spire Wealth Management held 66 shares of Corbus Pharmaceuticals worth $619 as of Q2 2026.
Spire Wealth Management left its Corbus Pharmaceuticals share count unchanged in Q2 2026.
Corbus Pharmaceuticals made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #2198 holding.
Spire Wealth Management first reported a position in Corbus Pharmaceuticals in Q1 2021 and has held it in 8 quarters since.
Spire Wealth Management's Corbus Pharmaceuticals position peaked at $117K in Q1 2021.
6 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.